Manifestation of pityriasis rosea and pityriasis rosea‐like eruptions after Covid‐19 vaccine: A systematic review [PDF]
Immunity, Inflammation and Disease, 2023 Background: After introducing Covid‐19 vaccines, a few side effects were reported, pityriasis rosea being one of them. Therefore, this study will systematically review its manifestation afteradministration.Methods: Databases were searched, covering a ...
Iman Khan +5 more
doaj +3 more sources
Pityriasis Rosea and Pityriasis Rosea-like Eruption Following COVID-19 Vaccinations: Case Series from Oman [PDF]
Oman Medical Journal, 2023 To mitigate the impact of the COVID-19 pandemic, several vaccines have been developed and administered to the public since 2021. A spectrum of cutaneous reactions has been reported among some of the vaccinated individuals.
Iman Al Hatmi +4 more
doaj +3 more sources
Dupilumab-induced pityriasis rosea [PDF]
JAAD Case Reports, 2023 IL: interleukin INTRODUCTION The T-helper-2 cytokines interleukin 4 (IL-4) and IL-13 play a key role in the pathogenesis of allergic disorders. Dupilumab is a fully human monoclonal antibody against the IL-4 alpha chain receptor, mitigating the T-helper ...
Morgan Zabel, BS +5 more
doaj +3 more sources
A Case of Persistent Pityriasis Rosea Successfully Treated by a Short Course of Therapy with Abrocitinib [PDF]
Clinical, Cosmetic and Investigational DermatologyHao Wu, Qing-Jie Ji, Yu-Yang Xu, Jian-Wei Zhu Department of Dermatology, Quzhou TCM Hospital at the Junction of Four Provinces Affiliated to Zhejiang Chinese Medical University, Quzhou, People’s Republic of ChinaCorrespondence: Jian-Wei Zhu, Email zjwmed@
Wu H, Ji QJ, Xu YY, Zhu JW
doaj +3 more sources
What’s old is new: Valacyclovir for the treatment of pityriasis rosea, a retrospective case series [PDF]
JAAD Case Reports, 2023 HHV: human herpesvirus PR: pityriasis rosea INTRODUCTION Pityriasis rosea (PR) is a common and self-limiting papulosquamous skin condition. It presents with the most distinguishable sign of a larger ‘‘herald’’ patch with a collarette of scale at the ...
Gina M. Ashforth, MD +4 more
doaj +3 more sources
Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review [PDF]
Clinical, Cosmetic and Investigational DermatologyLuca Potestio,* Fabrizio Martora,* Sara Cacciapuoti, Matteo Megna, Alessia Villani, Angelo Ruggiero Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy*These authors ...
Potestio L +5 more
doaj +3 more sources
Acral pityriasis rosea: A rare variant of pityriasis rosea [PDF]
Dermatology Reports, 2021 Pityriasis rosea (PR) is a common, selflimited inflammatory skin condition, usually affects the trunk and proximal extremities. A variety of atypical manifestations of PR have been recognized ranging from the difference in the morphology, distribution ...
Pimpa Tantanasrigul +2 more
doaj +5 more sources
American family physicianPityriasis rosea is a benign self-limiting rash, usually lasting 6 to 8 weeks. In classic pityriasis rosea a ‘herald patch’ is the initial finding, a large oval patch usually found on the torso.
Litchman G, Nair PA, Syed HA, Le JK.
europepmc +6 more sources
Purpuric pityriasis rosea in patients with anorexia nervosa. [PDF]
Dermatol ReportsPityriasis rosea (PR) is an exanthematous disease associated with the endogenous systemic reactivation of human herpesvirus (HHV)-6 and/or HHV-7. Variants of PR characterized by atypical lesion morphology, eruption course, and severe symptoms have ...
Ciccarese G +4 more
europepmc +2 more sources
Beyond the Herald Patch: Exploring the Complex Landscape of Pityriasis Rosea. [PDF]
Am J Clin DermatolPityriasis rosea (PR) is a prevalent dermatological condition characterized by a distinctive herald patch, followed by secondary eruptions, often forming a “Christmas tree” pattern on the trunk.
Mashoudy KD, Kim S, Farhadi L, Elman SA.
europepmc +2 more sources